Avacta | Smart Water Magazine

Avacta is developing novel cancer immunotherapies combining its two proprietary platforms – Affimer® biotherapeutics and pre|CISIONTM tumour targeted chemotherapy.

Web

Twitter

Appointments
Artificial intelligence (AI)
Biodiversity
Bottled water
Business
Circular Economy
Climate change
Cooperation
Desalination
Digital
Drinking Water
Drought
Education
Energy
Events
Floodings
Governance
Groundwater
Industrial
Infrastructure
Irrigation
Legislation
Mergers and Acquisitions
Mining
PPP
Pricing
Project tracking
Publications
Regulation
Research and development
Sanitation
Stormwater management
Sustainable Development Goals (SDG)
Tenders
Urban water cycle
Utilities
Waste water treatment
Water quality
Water security
Water Treatment